Tag: POETYK PSO-1

POETYK PSO-1 and 2: Long-term efficacy results of deucravacitinib in plaque psoriasis

Presented By
Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
POETYK PSO-LTE
Conference
WCD 2023
Type
Peer-reviewed article

31 August 2023 17:52

Novel oral psoriasis drug maintains efficacy over 2 years

Presented By
Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 3, POETYK-PSO-1
Conference
EADV 2022
Type
Peer-reviewed article

5 November 2022 10:36

Psoriasis treatment: no elevation of MACE and VTE on deucravacitinib

Presented By
Prof. Mark Lebwohl , Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 3, POETYK PSO-1, POETYK PSO-2
Conference
SPIN 2022
Type
Peer-reviewed article

26 August 2022 09:50

TYK2 inhibitor deucravacitinib shows impressive long-term response in psoriasis

Presented By
Prof. Richard Warren, University of Manchester, UK
Trial
Phase 3, POETYK PSO
Conference
EADV 2021
Type
Peer-reviewed article

18 November 2021 13:31

Existing and upcoming small molecules in psoriasis

Presented By
Dr Enikö Sonkoly , Karolinska University Hospital, Sweden
Trial
POETYK PSO; PSOARING
Conference
EADV 2021
Type
Peer-reviewed article

18 November 2021 13:19

Selective TYK2 inhibitor effective in moderate-to-severe plaque psoriasis

Trial
Phase 3, POETYK PSO-1, POETYK PSO-2
Conference
WPPAC 2021
Type
Peer-reviewed article

17 September 2021 10:59

Psoriasis: The treatment armamentarium continues to grow

Presented By
Prof. Bruce Strober, Yale University, CT, USA
Conference
AAD VMX 2021
Type
Peer-reviewed article

7 June 2021 13:32

Small molecule effective in moderate-to-severe psoriasis

Presented By
Prof. April Armstrong, Keck School of Medicine at UCLA, CA, USA
Trial
Phase 3, POETYK PSO-1 and 2
Conference
AAD VMX 2021
Type
Peer-reviewed article

7 June 2021 10:50
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com